2021 Form 10-K Financial Statement
#000121390022011571 Filed on March 10, 2022
Income Statement
Concept | 2021 | 2020 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | $175.0M | |
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $494.3K | $130.0K |
YoY Change | 280.26% | -0.76% |
% of Gross Profit | 0.28% | |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $694.3K | $290.0K |
YoY Change | 139.43% | 0.35% |
Operating Profit | $174.3M | -$288.9K |
YoY Change | -60436.13% | |
Interest Expense | $5.729M | -$290.0K |
YoY Change | -2075.45% | |
% of Operating Profit | 3.29% | |
Other Income/Expense, Net | $0.00 | -$380.0K |
YoY Change | -100.0% | -156.46% |
Pretax Income | $5.034M | -$961.7K |
YoY Change | -623.48% | -0.03% |
Income Tax | $0.00 | |
% Of Pretax Income | ||
Net Earnings | $5.034M | -$960.0K |
YoY Change | -624.42% | -0.21% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $230.1K | -$43.88K |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 | 2020 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.513M | $2.000M |
YoY Change | -24.38% | |
Cash & Equivalents | $1.513M | $2.000M |
Short-Term Investments | ||
Other Short-Term Assets | $103.1K | $300.0K |
YoY Change | -65.64% | |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $1.616M | $2.300M |
YoY Change | -29.76% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $175.1M | $175.0M |
YoY Change | 0.06% | |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $175.1M | $175.0M |
YoY Change | 0.06% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $1.616M | $2.300M |
Total Long-Term Assets | $175.1M | $175.0M |
Total Assets | $176.7M | $177.3M |
YoY Change | -0.32% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $256.2K | $200.0K |
YoY Change | 28.1% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $256.2K | $200.0K |
YoY Change | 28.1% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $15.66M | $21.30M |
YoY Change | -26.47% | |
Total Long-Term Liabilities | $15.66M | $21.30M |
YoY Change | -26.47% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $256.2K | $200.0K |
Total Long-Term Liabilities | $15.66M | $21.30M |
Total Liabilities | $15.92M | $21.50M |
YoY Change | -25.96% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $160.8M | $155.8M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $176.7M | $177.3M |
YoY Change | -0.32% |
Cashflow Statement
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | pmvc |
Common Stock Value One
CommonStockValueOne
|
437 | USD |
CY2020Q4 | pmvc |
Common Stock Value One
CommonStockValueOne
|
437 | USD |
CY2021 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
USD | |
pmvc |
Fair Value Initial Measurement
FairValueInitialMeasurement
|
14864500 | USD | |
CY2020Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
USD | |
pmvc |
Stock Issued During Period Value Founder Shares Forfeited Due To Nonexercise Of Overallotment Option
StockIssuedDuringPeriodValueFounderSharesForfeitedDueToNonexerciseOfOverallotmentOption
|
USD | ||
CY2021 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
USD | |
CY2020 | pmvc |
Proceeds From Maturity Of Securities In Trust Account
ProceedsFromMaturityOfSecuritiesInTrustAccount
|
USD | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
CY2021 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
USD | |
CY2021 | pmvc |
Proceeds From Sale Of Founder Shares
ProceedsFromSaleOfFounderShares
|
USD | |
CY2021 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
USD | |
CY2021 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
USD | |
CY2021 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001807765 | |
CY2020 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
130891 | USD |
CY2020 | pmvc |
Franchise Tax Expense
FranchiseTaxExpense
|
158000 | USD |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-288891 | USD |
CY2020 | us-gaap |
Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
|
40510 | USD |
CY2020 | us-gaap |
Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
|
379848 | USD |
CY2020 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-333500 | USD |
CY2020 | us-gaap |
Other Income
OtherIncome
|
-672838 | USD |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-961729 | USD |
CY2021 | pmvc |
Proceeds From Underwriters Rebate
ProceedsFromUnderwritersRebate
|
USD | |
CY2021 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
USD | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
USD | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD | |
CY2021 | pmvc |
Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
|
USD | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD | |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
USD | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
USD | ||
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
USD | |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
USD | ||
CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
USD | |
us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
USD | ||
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | ||
CY2020Q1 | pmvc |
Fair Value Of Warrant Liabilities
FairValueOfWarrantLiabilities
|
USD |